| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 00:07 | XFRA DIVIDEND INFORMATION - 13.02.2012 - 3 | | 81 | Xetra Newsboard |
| FOLGENDE WERTPAPIERE WERDEN AM 13.02.2012 EX DIVIDENDE GEHANDELT. THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 13.02.2012. INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT A1I XFRA US04315B1070...
Mehr lesen zu:
XFRA DIVIDEND INFORMATION - 13.02.2012 - 3 | |
| 00:07 | XETR DIVIDEND INFORMATION - 13.02.2012 - 2 | | 71 | Xetra Newsboard |
| FOLGENDE WERTPAPIERE WERDEN AM 13.02.2012 EX DIVIDENDE GEHANDELT. THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 13.02.2012. INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT LLY XETR US5324571083...
Mehr lesen zu:
XETR DIVIDEND INFORMATION - 13.02.2012 - 2 | |
| 12.02.
| Spectrum Pharmaceuticals is Among the Companies in the Biotechnology Industry With the Lowest EBITDA Growth | | 5 | SmarTrend |
| 12.02.
| Amgen To Near $100, Outperforming Pfizer | | 7 | Seeking Alpha |
| 12.02.
| Expecting Gilead To Break $70, Outperforming Merck | | 9 | Seeking Alpha |
| 11.02.
| Avanir Pharmaceuticals: The Perfect 2012 Stock For Cubs Fans | | - | Seeking Alpha |
| 11.02.
| Shares of BioMarin Pharmaceutical Rank the Highest in Terms of EBITDA Growth in the Biotechnology Industry | | 3 | SmarTrend |
| 11.02.
| Santarus is Among the Companies in the Pharmaceuticals Industry With the Highest EBITDA Growth | | - | SmarTrend |
| 11.02.
| Alexion Pharmaceuticals Shares Up 24.7% Since SmarTrend's Buy Recommendation | | 5 | SmarTrend |
| 11.02.
| 74.7% Return Seen to Date on SmarTrend Viropharma Call | | 2 | SmarTrend |
| 11.02.
| Uptrend Call Working As ISTA Pharmaceuticals Stock Rises 93.6% | | - | SmarTrend |
| 11.02.
| 51.7% Return Seen to Date on SmarTrend Maxygen Call | | - | SmarTrend |
| 10.02.
| Jury Rules Against Mylan In Sunovion Pharma Patent Litigation | | 244 | AFX News |
| CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced Friday that a jury has
rendered an unfavorable verdict in a patent infringement lawsuit filed by
Sunovion Pharmaceuticals Inc., f/k/a Sepracor...
Mehr lesen zu:
Jury Rules Against Mylan In Sunovion Pharma Patent Litigation | |
| 10.02.
| LIGAND PHARMACEUTICALS INC - 10-Q/A, Quarterly Report | | 2 | SEC Filings |
| 10.02.
| Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution | | 152 | PR Newswire |
| PITTSBURGH, Feb. 10, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that a jury has rendered an unfavorable verdict in a patent infringement lawsuit filed by Sunovion...
Mehr lesen zu:
Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution | |
| 10.02.
| Ligand Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 1.59% | | 1 | SmarTrend |
| 10.02.
| Incyte in Neutral Lane | | 1 | Zacks |
| 10.02.
| Medivation Announces Participation at Upcoming Investor Conferences | | 29 | MarketWire |
| SAN FRANCISCO, CA -- (Marketwire) -- 02/10/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following investor conferences in February:
Patrick Machado, chief...
Mehr lesen zu:
Medivation Announces Participation at Upcoming Investor Conferences | |
| 10.02.
| Exelixis Announces February 14 Webcast of Presentation at 14th Annual BIO CEO & Investor Conference | | 44 | Business Wire |
| Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey,
Ph.D., the company's president and chief executive officer, will present
at the 14th annual BIO...
Mehr lesen zu:
Exelixis Announces February 14 Webcast of Presentation at 14th Annual BIO CEO & Investor Conference | |
| 10.02.
| Regeneron Announces February 13, 2012 as Date of Full Year 2011 Financial and Operating Results Conference Call and Webcast | | 41 | PR Newswire |
| TARRYTOWN, N.Y., Feb. 10, 2012 /PRNewswire/ --Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2011 financial...
Mehr lesen zu:
Regeneron Announces February 13, 2012 as Date of Full Year 2011 Financial and Operating Results Conference Call and Webcast | |
